QyScore

JSON twin: https://www.healthaidb.com/software/qyscore.json

Company Name

Qynapse

Product URL

https://qynapse.com/qyscore/

Company URL

https://qynapse.com

Categories

• clinical Care
• diagnostic Support
• administrative Operations
• Clinical
• Diagnostic
• Administrative

Summary

QyScore® is an AI-powered neuroimaging analysis platform designed to enhance the diagnosis and monitoring of central nervous system (CNS) diseases by providing automated, precise brain MRI analyses.

Description

QyScore® offers automated quantification of brain structures and lesions from MRI scans, facilitating early detection and monitoring of CNS diseases such as Alzheimer's, multiple sclerosis, and Parkinson's. The platform generates automated patient reports and integrates with existing clinical workflows, aiming to reduce image reading variability and segmentation errors by 89%. It is FDA-cleared and CE-marked, supporting both clinical routine and clinical trial applications.

Api Available

unknown

Certifications

• CE Certification
• FDA 510(k) clearance
• ISO 27001
• ISO 9001

Company Founding

2015

Company Offices

• France
• United States
• Germany
• United Kingdom
• Canada
• Australia
• Japan
• South Korea
• China
• India

Compliance

• HIPAA
• GDPR
• ISO 27001
• ISO 9001
• CE Certification
• FDA 510(k) clearance

Customers

Data Residency

EU, US, other regions

Data Standards

• DICOM
• HL7
• FHIR

Deployment Model

• cloud-based
• hybrid
• on-premises
• virtualized

Features

• Automated neuroimaging analysis
• Quantification of neuroinflammation and neurodegeneration
• Whole brain, white matter, grey matter by lobe, cerebellum analysis
• White matter abnormalities detection
• Brain substructures analysis
• Automated patient report generation
• 3D visualization platform integration
• Reduced image reading variability
• Reduced segmentation errors
• Enhanced precision and accuracy

Id

SW0526

Integration Partners

Integrations

• PACS
• AI marketplace
• distribution platform
• stand-alone web-based

Languages Supported

• English
• French
• German
• Spanish
• Italian
• Dutch
• Swedish
• Norwegian
• Portuguese
• Russian
• Chinese
• Japanese
• Korean
• Hindi
• Arabic
• Turkish
• Polish
• Czech
• Hungarian
• Romanian

Last Updated

2025-10-11

License

commercial

Market Segment

• enterprise
• smb
• consumer

Optional Modules

• Ischemic Stroke analysis
• Huntington’s Disease analysis
• Epilepsy analysis
• Traumatic Brain Injury analysis
• Schizophrenia analysis
• Depression analysis

Os Platforms

• web-based

Pricing Details

Contact vendor for pricing information.

Pricing Model

subscription

Privacy Features

• data minimization
• anonymization
• pseudonymization
• data residency compliance
• user data control
• data sharing controls

Product Code

SW0526

Product Name

QyScore

Ratings

Regions Available

• United States
• European Union
• Canada
• Australia
• Japan
• South Korea
• China
• India
• Brazil
• Mexico
• South Africa
• Russia
• United Kingdom
• Germany
• France
• Italy
• Spain
• Netherlands
• Belgium
• Sweden
• Norway

Related Urls

• https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices

Release Year

Security Features

• end-to-end encryption
• zero-trust architecture
• privacy by design
• SOC 2 Type II compliance
• regular security assessments
• penetration testing
• multi-factor authentication
• role-based access control
• continuous monitoring
• incident response planning

Specialties

• Neurology
• Radiology
• Geriatrics
• Psychiatry
• Neurosurgery

Support Channels

System Requirements

cloud-based, hybrid, on-premises, virtualized

Target Users

• clinicians
• radiologists
• neurologists
• researchers
• patients

Training Options

Type

product

User Reviews

Version

1.0

Alternatives

See related products

Canonical JSON

{
  "product_name": "QyScore",
  "company_name": "Qynapse",
  "product_url": "https://qynapse.com/qyscore/",
  "company_url": "https://qynapse.com",
  "related_urls": [
    "https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices"
  ],
  "product_code": "SW0526",
  "summary": "QyScore® is an AI-powered neuroimaging analysis platform designed to enhance the diagnosis and monitoring of central nervous system (CNS) diseases by providing automated, precise brain MRI analyses.",
  "description": "QyScore® offers automated quantification of brain structures and lesions from MRI scans, facilitating early detection and monitoring of CNS diseases such as Alzheimer's, multiple sclerosis, and Parkinson's. The platform generates automated patient reports and integrates with existing clinical workflows, aiming to reduce image reading variability and segmentation errors by 89%. It is FDA-cleared and CE-marked, supporting both clinical routine and clinical trial applications.",
  "categories": [
    "clinical Care",
    "diagnostic Support",
    "administrative Operations",
    "Clinical",
    "Diagnostic",
    "Administrative"
  ],
  "market_segment": [
    "enterprise",
    "smb",
    "consumer"
  ],
  "target_users": [
    "clinicians",
    "radiologists",
    "neurologists",
    "researchers",
    "patients"
  ],
  "specialties": [
    "Neurology",
    "Radiology",
    "Geriatrics",
    "Psychiatry",
    "Neurosurgery"
  ],
  "regions_available": [
    "United States",
    "European Union",
    "Canada",
    "Australia",
    "Japan",
    "South Korea",
    "China",
    "India",
    "Brazil",
    "Mexico",
    "South Africa",
    "Russia",
    "United Kingdom",
    "Germany",
    "France",
    "Italy",
    "Spain",
    "Netherlands",
    "Belgium",
    "Sweden",
    "Norway"
  ],
  "languages_supported": [
    "English",
    "French",
    "German",
    "Spanish",
    "Italian",
    "Dutch",
    "Swedish",
    "Norwegian",
    "Portuguese",
    "Russian",
    "Chinese",
    "Japanese",
    "Korean",
    "Hindi",
    "Arabic",
    "Turkish",
    "Polish",
    "Czech",
    "Hungarian",
    "Romanian"
  ],
  "pricing_model": "subscription",
  "pricing_details": "Contact vendor for pricing information.",
  "license": "commercial",
  "company_offices": [
    "France",
    "United States",
    "Germany",
    "United Kingdom",
    "Canada",
    "Australia",
    "Japan",
    "South Korea",
    "China",
    "India"
  ],
  "company_founding": "2015",
  "deployment_model": [
    "cloud-based",
    "hybrid",
    "on-premises",
    "virtualized"
  ],
  "os_platforms": [
    "web-based"
  ],
  "features": [
    "Automated neuroimaging analysis",
    "Quantification of neuroinflammation and neurodegeneration",
    "Whole brain, white matter, grey matter by lobe, cerebellum analysis",
    "White matter abnormalities detection",
    "Brain substructures analysis",
    "Automated patient report generation",
    "3D visualization platform integration",
    "Reduced image reading variability",
    "Reduced segmentation errors",
    "Enhanced precision and accuracy"
  ],
  "optional_modules": [
    "Ischemic Stroke analysis",
    "Huntington’s Disease analysis",
    "Epilepsy analysis",
    "Traumatic Brain Injury analysis",
    "Schizophrenia analysis",
    "Depression analysis"
  ],
  "integrations": [
    "PACS",
    "AI marketplace",
    "distribution platform",
    "stand-alone web-based"
  ],
  "data_standards": [
    "DICOM",
    "HL7",
    "FHIR"
  ],
  "api_available": "unknown",
  "system_requirements": "cloud-based, hybrid, on-premises, virtualized",
  "compliance": [
    "HIPAA",
    "GDPR",
    "ISO 27001",
    "ISO 9001",
    "CE Certification",
    "FDA 510(k) clearance"
  ],
  "certifications": [
    "CE Certification",
    "FDA 510(k) clearance",
    "ISO 27001",
    "ISO 9001"
  ],
  "security_features": [
    "end-to-end encryption",
    "zero-trust architecture",
    "privacy by design",
    "SOC 2 Type II compliance",
    "regular security assessments",
    "penetration testing",
    "multi-factor authentication",
    "role-based access control",
    "continuous monitoring",
    "incident response planning"
  ],
  "privacy_features": [
    "data minimization",
    "anonymization",
    "pseudonymization",
    "data residency compliance",
    "user data control",
    "data sharing controls"
  ],
  "data_residency": "EU, US, other regions",
  "customers": [],
  "user_reviews": [],
  "ratings": [],
  "support_channels": [],
  "training_options": [],
  "release_year": "",
  "integration_partners": [],
  "id": "SW0526",
  "slug": "qyscore",
  "type": "product",
  "version": "1.0",
  "last_updated": "2025-10-11",
  "links_json": {
    "self": "https://www.healthaidb.com/software/qyscore.json"
  }
}